Bristol Myers trades higher after the FDA approves an oral medication for schizophrenia in adults, fiscal fourth-quarter ...

Shorter-term technical measures like the stock’s 50-day and 200-day suggest that the stock’s current bullish momentum is ...

Even with its near-flat revenue growth, Costco was still able to boost its gross margin from 11.9% to 12.4%. Operating income ...

In a report released today, Michael Baker from D.A. Davidson maintained a Hold rating on Costco (COST – Research Report). The ...

These are the top stocks that gained the attention of retail traders and investors throughout the day: Alibaba Group Holding ...

Costco stock is lower Friday after the membership warehouse firm reported a top-line miss in its fiscal fourth quarter, but ...

Wells Fargo analyst Edward Kelly has maintained their neutral stance on COST stock, giving a Hold rating today. Edward Kelly has given his ...

Shares of NVIDIA remain in a long-term bullish trend with a target price of $150. Shares of Costco ( COST) are at the top of ...

Shares jumped 6% in premarket trading after the Food and Drug Administration approved a treatment for [schizophrenia patients]( ...

U.S. stocks traded higher this morning, with the Dow Jones index rising more than 100 points on Friday. Following the market ...

Costco shares keep churning higher, but those gains have come predominantly from multiple expansion rather than earnings ...